Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy

Fig. 3

Stack bars of self-assessed daily symptom severity reported by patients in diaries during the two weeks treatment period, severities of individual symptoms assessed on 5-point Likert times are summed up; Significant differences compared to day 1 are marked by stars, *: p < 0.01, **: p < 0.001, ***: p < 0.0001; N = 30–33.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us